A phase II prospective study of selumetinib in children with recurrent or refractory low-grade glioma (LGG): A Pediatric Brain Tumor Consortium (PBTC) study.
暂无分享，去创建一个
I. Pollack | A. Ligon | N. Lindeman | J. Fangusaro | L. Doyle | Malcolm A. Smith | R. Packer | G. Dhall | M. Fouladi | P. Fisher | I. Qaddoumi | A. Onar-Thomas | S. Kreissman | I. Dunkel | Shengjie Wu | R. Jakacki | A. Banerjee | L. Kilburn | P. Baxter | T. Young-Poussaint